rs1799983 — NOS3 Glu298Asp
Nitric oxide production - reduced activity increases cardiovascular risk and oxidative stress
Details
- Gene
- NOS3
- Chromosome
- 7
- Risk allele
- T
- Protein change
- p.Glu298Asp
- Consequence
- Missense
- Inheritance
- Codominant
- Clinical
- Risk Factor
- Evidence
- Established
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Methylation & DetoxNOS3 Glu298Asp - Nitric Oxide and Cardiovascular Health
Endothelial nitric oxide synthase (eNOS), encoded by the NOS3 gene, produces nitric oxide (NO) in the lining of blood vessels. Nitric oxide is one of the most important molecules in cardiovascular biology - it relaxes blood vessel walls, prevents blood clots from forming, and reduces inflammation in the arterial lining.
The Mechanism
The Glu298Asp 11 Glutamic acid to aspartic acid at position 298 variant (rs1799983) replaces glutamic acid with aspartic acid at position 298 of the eNOS protein. The T allele (Asp) makes the enzyme more susceptible to cleavage and degradation, reducing the steady-state amount of functional eNOS in endothelial cells. Less enzyme means less nitric oxide production, which can lead to stiffer blood vessels, higher blood pressure, and increased oxidative stress.
The Uncoupling Problem
When eNOS is impaired, it can become "uncoupled" 22 Uncoupled eNOS produces harmful superoxide instead of beneficial nitric oxide - instead of producing beneficial nitric oxide, it generates superoxide, a harmful reactive oxygen species. This switches the enzyme from being protective to actively damaging. Adequate levels of BH4 33 BH4 is an essential cofactor that keeps eNOS in its coupled, NO-producing state (tetrahydrobiopterin), a critical cofactor, help prevent uncoupling.
The Evidence
A large meta-analysis44 large meta-analysis
Casas JP et al. Endothelial Nitric Oxide Synthase Genotype and Ischemic Heart Disease. Circulation, 2004 of 26 studies involving 23,028 individuals confirmed that the TT genotype
is associated with increased risk of ischemic heart disease (OR 1.31, 95% CI 1.13-1.51).
A subsequent meta-analysis of 60 studies55 meta-analysis of 60 studies
Association between eNOS rs1799983 polymorphism and hypertension. BMC Cardiovasc Disord, 2021
involving 14,185 hypertension cases and 13,407 controls found significant associations
under all genetic models (TT vs GG: OR 1.80, 95% CI 1.41-2.31). The effect is
more pronounced when combined with the NOS3 promoter variant (rs2070744) and lifestyle
factors like smoking, sedentary behavior, and poor diet.
Practical Implications
Dietary nitrates from beets, spinach, and arugula can boost NO production through an alternative pathway 66 Oral bacteria convert dietary nitrate to nitrite, which is then reduced to NO in the acidic stomach environment that bypasses eNOS entirely. Regular aerobic exercise is one of the most potent stimulators of eNOS activity and NO production. Vitamin C and other antioxidants help prevent eNOS uncoupling by supporting BH4 recycling.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Normal nitric oxide production
Your NOS3 enzyme produces nitric oxide normally. Nitric oxide is crucial for blood vessel health, blood pressure regulation, and cardiovascular function. About 36% of Europeans share this genotype.
Mildly reduced nitric oxide production
You carry one variant that reduces nitric oxide production. When NO production is low, the enzyme may produce superoxide (a harmful oxidant) instead. About 48% of Europeans share this genotype.
Significantly reduced nitric oxide production
You have two NOS3 variants. Nitric oxide production is impaired, increasing cardiovascular risk (OR 1.31 for ischemic heart disease, OR 1.80 for hypertension). About 16% of Europeans share this genotype.
Key References
Casas et al. meta-analysis of 26 studies (23,028 subjects) showing Asp298 homozygosity increases IHD risk (OR 1.31)
Meta-analysis of 60 studies (14,185 cases, 13,407 controls) confirming rs1799983 association with hypertension (OR 1.44)
Systematic review and meta-analysis of Glu298Asp variant and acute coronary syndrome risk
Nakayama et al. significance of NOS3 Glu298Asp and T-786C variants in coronary artery spasm